Relationships between the factors of innate immune system and results of neurocognitive function parameters in the persons living with HIV infection: interim results of the study

Cover Page

Cite item

Full Text

Abstract

HIV infection is closely associated with damage to the nervous system, even despite usage of antiretroviral therapy. Thus, the patients are at a high risk for neurological complications. Due to limited permeability of the blood-brain barrier, the opportunity of its damage, both directly by the proteins of HIV-infected cells and indirectly, by immune system, e.g., inducing the production of inflammatory mediators, the involvement of the central nervous system in pathogenesis of HIV infection seems to be only a matter of time. HIV-associated neurocognitive disorders (HAND) comprise a poly-etiological pathological condition associated with direct and indirect damage to neurons in HIV infection. The role of interaction between the innate immune system and nervous system mediators in viral infections suggests that the specific changes in content and ratios of pro- and anti-inflammatory cytokines that are among the most polypotent mediators of immune regulation can be detectable in the persons prone to the development of HAND in HIV infection. The purpose of the present study was to characterize the features of serum content and the relationship between the indexes of innate immunity factors with the results of neurocognitive testing in the persons living with HIV.

123 persons were included in the study, of which 93 subjects live with HIV infection. They were divided into 3 groups according to the stages of HIV infection, according to the Russian Classification of HIV infection. 30 persons represented a group of healthy volunteers, comparable in age and gender with the members of main groups, and served as a control group. Determination of IL-1β and IL-10 contents in blood serum was carried out by solid-phase enzyme immunoassay. The level of CD4+T lymphocytes was determined by flow cytometry. Neurocognitive testing using Schulte tables, the Munsterberg test was conducted by a medical psychologist, according to generally accepted methods.

A significant increase in the serum IL-10 content in subjects from the main groups was revealed as compared with the control group, as well as in group III compared with the values groups I and II. The levels of IL- 1β, CD4+T lymphocytes were significantly lower in group III, compared with all other groups. The personal performance index determined by testing with Schulte tables was reduced in all groups, relative to the controls, with a significant predominance of the results in groups I and II over the results of the participants from group III. The scores in Munsterberg test were equally diminished in all the main groups compared to the control values. When assessing the Spearman coefficient, the presence of various correlation profiles was established, depending on the stage of the disease.

About the authors

S. V. Knysh

Pacific State Medical University

Author for correspondence.
Email: immunolog.vl@gmail.com

PhD (Medicine), Associate Professor, Department of Normal and Pathological Physiology

Russian Federation, Vladivostok

L. F. Sklyar

M. Vladimirsky Regional Research and Clinical Institute

Email: immunolog.vl@gmail.com

PhD, MD (Medicine), Professor, Department of Infectious Diseases

Russian Federation, Moscow

Yu. S. Cherkasova

Regional Clinical Hospital No. 2

Email: immunolog.vl@gmail.com

Medical Psychologist

Russian Federation, Vladivostok

A. A. Chernikova

Regional Clinical Hospital No. 2; Far Eastern Federal University

Email: immunolog.vl@gmail.com

PhD (Medicine), Deputy Head for Prevention and Control of AIDS and Infectious Diseases; Associate Professor, School of Medicine

Russian Federation, Vladivostok; Vladivostok

A. A. Knysh

Pacific State Medical University

Email: immunolog.vl@gmail.com

Student, Clinical Psychology, Faculty of Public Health

Russian Federation, Vladivostok

Tatiana A. Nevezhkina

Pacific State Medical University

Email: immunolog.vl@gmail.com

Assistant Professor, Department of Normal and Pathological Physiology

Russian Federation, Vladivostok

E. A. Chagina

Pacific State Medical University

Email: immunolog.vl@gmail.com

PhD (Medicine), Associate Professor, Department of Normal and Pathological Physiology

Russian Federation, Vladivostok

References

  1. Боева Е.В., Беляков Н.А. Синдром восстановления иммунитета при ВИЧ-инфекции // Инфекция и иммунитет, 2018. Т. 8, № 2. C. 139-149. [Boeva E.V., Belyakov N.A. Immune reconstitution inflammatory syndrome in HIV infection. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2018, Vol. 8, no. 2, pp. 139-149. (In Russ.)] doi: 10.15789/2220-7619-2018-2-139-149.
  2. ВИЧ-инфекция в Российской Федерации на 31 декабря 2021 г. [Электронный ресурс] // Специализированный научно-исследовательский отдел по профилактике и борьбе со СПИДом ФБУН Центрального НИИ эпидемиологии Роспотребнадзора. – 2022. Режим доступа: http://www.hivrussia.info/wp-content/uploads/2022/03/Spravka-VICH-v-Rossii-na-31.12.2021-g..pdf. [HIV infection in the Russian Federation on December 31, 2021 [Electronic resource] // Specialized Research Department for the Prevention and Control of AIDS of the Central Research Institute of Epidemiology of Rospotrebnadzor. 2022]. Access mode: http://www.hivrussia.info/wp-content/uploads/2022/03/Spravka-VICH-v-Rossii-na-31.12.2021-g..pdf.
  3. Кныш С.В., Маркелова Е.В., Зенина А.А., Костюшко А.В., Федянина Л.Н. Роль белка S100b и BDNF в иммунопатогенезе нейровоспаления у лиц с индуцированной иммунокомпрометацией // Российский иммунологический журнал, 2021. Т. 24, № 2. C. 237-242. [Knysh S.V., Markelova E.V., Zenina A.A., Kostushko A.V., Fedyanina L.N. Role of S100b protein and BDNF in immunopathogenesis of neuroinflammation in the patients with induced immunocompromised state. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2021, Vol. 24, no. 2, pp. 237-242. (In Russ.)]
  4. Кныш С.В., Маркелова Е.В., Симакова А.И., Караулов А.В. Показатели системы нейропептидов в острый период опоясывающего герпеса // Инфекция и иммунитет, 2020. Т. 10, № 2. С. 329-337. [Knysh S.V., Markelova E.V., Simakova A.I., Karaulov A.V. Neuropeptide system parameters in acute herpes zoster. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2020, Vol. 10, no. 2, pp. 329-337. (In Russ.)] doi: 10.15789/2220-7619-TFO-1256.
  5. Трофимова Т.Н., Катаева Г.В., Громова Е.А., Рассохин В.В., Боева Е.В., Симакина О.Е., Беляков Н.А. ВИЧ-ассоциированные нейрокогнитивные нарушения: диагностика, выявление причин и эффективность терапии // ВИЧ-инфекция и иммуносупрессии, 2018. Т. 10, № 4. С. 7-24. [Trofimova T.N., Katayeva G.V., Gromova E.A., Rassokhin V.V., Boeva E.V., Simakina O.E., Belyakov N.A. HIV-associated neurocognitive disorders: diagnosis, detection of causes and therapy efficiency. VICh-infektsiya i immunosupressii = HIV Infection and Immunosuppressive Disorders, 2018, Vol. 10, no. 4, pp. 7-24. (In Russ.)]
  6. Bertrand L., Nair M., Toborek M. Solving the blood-brain barrier challenge for the effective treatment of HIV replication in the central nervous system. Curr. Pharm. Des., 2016, Vol. 22, no. 35, pp. 5477-5486.
  7. Bertrand L., Velichkovska M., Toborek, M. Cerebral Vascular Toxicity of Antiretroviral Therapy. J. Neuroimmune Pharmacol., 2021, Vol. 16, pp. 74-89.
  8. Chen L., Yang J., Zhang R, Xu Y., Zheng J., Jiang J., Jiang J., He L., Wang N., Yeung P.C., Oan X. Rates and risk factors associated with the progression of HIV to AIDS among HIV patients from Zhejiang, China between 2008 and 2012. AIDS Res. Ther., 2015, Vol. 12, 32. doi: 10.1186/s12981-015-0074-7.
  9. Harper J., Ribeiro S.P., Chan C.N., Aid M., Deleage C., Micci L., Pino M., Cervasi B., Raghunathan G., Rimmer E., Ayanoglu G., Wu G., Shenvi N., Barnard R.J., Del Prete G.Q., Busman-Sahay K., Silvestri G., Kulpa D.A., Bosinger S.E., Easley K.A., Howell B.J., Gorman D., Hazuda D.J., Estes J.D., Sekaly R.P., Paiardini M. Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy. J. Clin. Invest., 2022, Vol. 132, no. 8, e155251. doi: 10.1172/JCI155251.
  10. McRae M. HIV and viral protein effects on the blood brain barrier. Tissue Barriers, 2016, Vol. 4, no. 1, e1143543. doi: 10.1080/21688370.2016.1143543.
  11. Osuji F.N., Onyenekwe C.C., Ahaneku J.E., Nkiruka R.U. The effects of highly active antiretroviral therapy on the serum levels of pro-inflammatory and anti-inflammatory cytokines in HIV infected subjects. J. Biomed. Sci., 2018, Vol. 25, 88. doi: 10.1186/s12929-018-0490-9.
  12. Vastag Z., Fira-Mladinescu O., Rosca E.C. HIV-Associated Neurocognitive Disorder (HAND): Obstacles to Early Neuropsychological Diagnosis. Int. J. Gen. Med., 2022, Vol. 15, pp. 4079-4090.
  13. Villacres M.C., Kono N., Mack W.J., Nowicki M.J., Anastos K., Augenbraun M., Liu C., Landay A., Greenblatt R.M., Gange S.J., Levine A.M. Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection. J. Infect. Dis., 2012, Vol. 206, no. 5, pp. 780-789. doi: 10.1093/infdis/jis380.
  14. Xie Y., Sun J., Wei L., Jiang H., Hu C., Yang J., Huang Y., Ruan B., Zhu B. Altered gut microbiota correlate with different immune responses to HAART in HIV-infected individuals. BMC Microbiol., 2021, Vol. 21, 11. doi: 10.1186/s12866-020-02074-1.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2022 Knysh S.V., Sklyar L.F., Cherkasova Y.S., Chernikova A.A., Knysh A.A., Nevezhkina T.A., Chagina E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies